Trial · NCT07908862
Effects of Transcranial Direct Current Stimulation on Cyberaggressive Behaviour in Adults
NCT07908862, Not applicable, Not yet recruiting, Nanyang Technological University
3 sourcestrials-2026-11-12-0.5.0
Cite this record
ConductScience Library. Effects of Transcranial Direct Current Stimulation on Cyberaggressive Behaviour in Adults. Trials, record NCT07908862. Release trials-2026-11-12-0.5.0, 12 Nov 2026. https://conductscience.org/library/trials/NCT07908862
On this page
Trial
As registered on ClinicalTrials.gov, in the graph's capture of the registry.
- Title
- Effects of Transcranial Direct Current Stimulation on Cyberaggressive Behaviour in Adults
- NCT number
- NCT07908862
- Status
- Not yet recruiting
- Phases
- Not applicable
- Enrollment
- 159 participants, estimated
- Lead sponsor
- Nanyang Technological University
- Conditions
- Cyberaggression
- Interventions
- Anodal transcranial direct current stimulation, Cathodal transcranial direct current stimulation, Sham transcranial direct current stimulation
- First posted
- 2026-11-02
- Last updated
- 2026-11-02
Source ClinicalTrials.gov
Registered outcomes3
Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.
| List | Outcome | Time frame | Description |
|---|---|---|---|
| Primary | Cyberaggressive responding on the TAP-Chat task | Day 3 (during the TAP-Chat task following the third tDCS session) | Cyberaggressive responding will be assessed from participant-generated messages during the Taylor Aggression Paradigm-Chat (TAP-Chat) task. Responses will be coded using a pre-specified coding scheme for cyberaggressive content. The primary analysis will compare coded cyberaggressive responding across the anodal, cathodal, and sham tDCS conditions and across the two levels of provocation. |
| Other | Aggressive responding on the Taylor Aggression Paradigm | Day 1 (during the TAP task following the first tDCS session) | Aggressive responding will be assessed using the Taylor Aggression Paradigm (TAP), a laboratory-based competitive reaction-time task in which participants can select an aversive stimulus for an ostensible opponent. Aggressive responding will be quantified from participants' selections during the task according to the pre-specified TAP scoring procedure. |
| Other | Heart rate variability during TAP-Chat | Day 3 (during the TAP-Chat task following the third tDCS session) | Heart rate variability (HRV) will be derived from electrocardiogram (ECG) recordings collected during the Session 3 TAP-Chat task. HRV will be quantified using the root mean square of successive differences (RMSSD) and examined during pre-specified periods of the task to characterize autonomic responses associated with the online competitive interaction and provocation. |
Source ClinicalTrials.gov
Outcomes0
Each outcome the trial posted results for, in ClinicalTrials.gov's words.
None in this release.
Results by group0
Each measurement the trial posted, group by group, in the words and numbers it posted.
None in this release.
Participant flow0
How many started, completed or left each group, period by period.
None in this release.
Adverse events0
Each adverse event the trial posted, group by group: the participants affected out of those at risk.
None in this release.
Adverse event totals0
The totals the trial posted for each group.
None in this release.
Papers2
The papers the trial lists on ClinicalTrials.gov.
Grants0
The grants NIH RePORTER links to the trial, newest funded first: NIH's, and some of AHRQ's, CDC's, FDA's and VA's. Each shows its title, principal investigators, organization and funder in its newest year.
None in this release.
Trial comparisons0
Comparisons of the trial's two groups, calculated by ConductScience from the counts it posted.
None in this release.
Tests0
The ConductCognition tests this trial's registered outcomes name, as ScienceGraph matched them in trial-tests-2026-11-12-0.2.1.
None in this release.
Data dates
The day each source was copied for this release.
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this trial from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/trials/v1/NCT07908862
GET https://conductscience.org/api/trials/v1/NCT07908862/registered